Netherlands Biotechnology & Medical Research

Pharvaris NV (PHVS)

Track

Pharvaris NV has seen significant insider selling over the past 90 days, with 63 transactions totaling approximately $19.75 million in sales and no recorded buys. Key executives and directors, including the CEO and Chief Early Development officer, have executed planned and proposed sales. This activity follows a recent earnings report that missed expectations.
Ticker: PHVS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Pharvaris NV. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 13 Jul 2026
Value US$1,017,882.85 | Price 310.55 | Shares 81,328 (-14.9%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-15 2026-07-13 PlS Planned sale
Modig Berndt

Chief Executive Officer

Executive Director
81,328 -14.9%
310.55
US$1,017,883 		81,328 -14.9% 310.55 US$1,017,883
2026-07-13 2026-07-13 PrS Proposed sale
Berndt B.A,E. Modig

Director; Officer

Executive Director
69,316
341.93
US$1,323,697 		69,316 341.93 US$1,323,697
2026-07-01 2026-06-30 PlS Planned sale
Schikan Johannes Gerardus Christiaan Petrus
Non-Executive Director
58,580 -18.2%
269.89
US$4,509,672 		58,580 -18.2% 269.89 US$4,509,672
2026-07-01 2026-06-30 PlS Planned sale
Lesage Anne

Chief Early Development

Officer
30,703 -24.6%
35.49
US$1,089,637 		30,703 -24.6% 35.49 US$1,089,637
2026-07-01 2026-06-30 PlS Planned sale
Lesage Anne

Chief Early Development

Officer
27,872 -32.2%
35.48
US$988,890 		27,872 -32.2% 35.48 US$988,890
2026-06-30 2026-06-30 PrS Proposed sale
GrayMatters Consulting B.V.

Officer

Officer
30,703
34.71
US$1,065,701 		30,703 34.71 US$1,065,701
2026-06-30 2026-06-30 PrS Proposed sale
ANNE SIMONNE J. LESAGE

Officer

Officer
27,872
34.71
US$967,437 		27,872 34.71 US$967,437
2026-06-30 2026-06-30 PrS Proposed sale
Hans H. Schikan

Director

Non-Executive Director
30,712
34.71
US$1,066,014 		30,712 34.71 US$1,066,014
2026-06-30 2026-06-30 PrS Proposed sale
Hans H. Schikan

Director

Non-Executive Director
30,712
34.71
US$1,066,014 		30,712 34.71 US$1,066,014
2026-07-01 2026-06-29 PlS Planned sale
Schikan Johannes Gerardus Christiaan Petrus
Non-Executive Director
6,888 -2.0%
35.05
US$241,447 		6,888 -2.0% 35.05 US$241,447
2026-07-01 2026-06-29 PlS Planned sale
Lesage Anne

Chief Early Development

Officer
6,997 -5.3%
35.05
US$245,232 		6,997 -5.3% 35.05 US$245,232
2026-07-01 2026-06-29 PlS Planned sale
Lesage Anne

Chief Early Development

Officer
8,300 -12.4%
35.05
US$290,908 		8,300 -12.4% 35.05 US$290,908
2026-07-01 2026-06-29 PlS Planned sale
Lesage Anne

Chief Early Development

Officer
2,300 -3.9%
35.12
US$80,786 		2,300 -3.9% 35.12 US$80,786
2026-06-29 2026-06-29 PlS Planned sale
Schikan Johannes Gerardus Christiaan Petrus
Non-Executive Director
2,400 -0.7%
35.10
US$84,250 		2,400 -0.7% 35.10 US$84,250
2026-06-29 2026-06-29 PrS Proposed sale
Hans H. Schikan

Director

Non-Executive Director
6,888
34.01
US$234,261 		6,888 34.01 US$234,261
2026-06-29 2026-06-29 PrS Proposed sale
GrayMatters Consulting B.V.

Officer

Officer
6,997
34.01
US$237,968 		6,997 34.01 US$237,968
2026-06-29 2026-06-29 PrS Proposed sale
ANNE SIMONNE J. LESAGE

Officer

Officer
8,300
34.01
US$282,283 		8,300 34.01 US$282,283
2026-06-29 2026-06-26 PlS Planned sale
Lu Peng

Chief Medical Officer

Officer
14,700 -18.3%
34.00
US$499,847 		14,700 -18.3% 34.00 US$499,847
2026-06-26 2026-06-26 PrS Proposed sale
PENG LU

Officer

Officer
14,700
33.30
US$489,510 		14,700 33.30 US$489,510
2026-06-26 2026-06-26 PrS Proposed sale
PENG LU

Officer

Officer
14,700
33.30
US$489,510 		14,700 33.30 US$489,510
2026-06-29 2026-06-25 PlS Planned sale
Lesage Anne

Chief Early Development

Officer
2,300 -1.7%
35.12
US$80,786 		2,300 -1.7% 35.12 US$80,786
2026-06-29 2026-06-25 PlS Planned sale
Lesage Anne

Chief Early Development

Officer
2,300 -3.9%
35.12
US$80,775 		2,300 -3.9% 35.12 US$80,775
2026-06-29 2026-06-25 PlS Planned sale
Lu Peng

Chief Medical Officer

Officer
3,400 -4.9%
35.09
US$119,310 		3,400 -4.9% 35.09 US$119,310
2026-06-29 2026-06-25 PlS Planned sale
Lu Peng

Chief Medical Officer

Officer
11,600 -14.4%
34.45
US$399,675 		11,600 -14.4% 34.45 US$399,675
2026-06-25 2026-06-25 PrS Proposed sale
PENG LU

Officer

Officer
15,000
33.29
US$499,350 		15,000 33.29 US$499,350
2026-06-25 2026-06-25 PrS Proposed sale
ANNE SIMONNE J. LESAGE

Officer

Officer
2,300
33.29
US$76,567 		2,300 33.29 US$76,567
2026-06-25 2026-06-25 PrS Proposed sale
Hans H. Schikan

Director

Non-Executive Director
2,400
33.29
US$79,896 		2,400 33.29 US$79,896
2026-06-25 2026-06-25 PrS Proposed sale
GrayMatters Consulting B.V.

Officer

Officer
2,300
33.29
US$76,567 		2,300 33.29 US$76,567
2026-06-23 2026-06-18 PlS Planned sale
Lu Peng

Chief Medical Officer

Officer
300 -0.5%
34.00
US$10,200 		300 -0.5% 34.00 US$10,200
2026-06-18 2026-06-18 PrS Proposed sale
PENG LU

Officer

Officer
300
33.41
US$10,023 		300 33.41 US$10,023
2026-06-17 2026-06-15 PlS Planned sale
Modig Berndt

Chief Executive Officer

Executive Director
100 -0.1%
31.46
US$3,146 		100 -0.1% 31.46 US$3,146
2026-06-17 2026-06-15 PlS Planned sale
Modig Berndt

Chief Executive Officer

Executive Director
2,191 -1.6%
31.05
US$68,027 		2,191 -1.6% 31.05 US$68,027
2026-06-15 2026-06-15 PrS Proposed sale
Berndt B.A.E. Modig

Director; Officer

Executive Director
2,291
30.72
US$70,380 		2,291 30.72 US$70,380
2026-06-08 2026-06-04 S Sale
Nijdam Anna

Principal Accounting Officer

Officer
2,670 -5.5%
30.87
US$82,425 		2,670 -5.5% 30.87 US$82,425
2026-06-04 2026-06-04 PrS Proposed sale
ANNA NIJDAM

Officer

Officer
2,670
30.87
US$82,425 		2,670 30.87 US$82,425
2026-05-26 2026-05-22 S Sale
Nijdam Anna

Principal Accounting Officer

Officer
5,501 -10.1%
30.74
US$169,084 		5,501 -10.1% 30.74 US$169,084
2026-05-22 2026-05-22 PrS Proposed sale
ANNA NIJDAM

Officer

Officer
5,501
30.74
US$169,084 		5,501 30.74 US$169,084
2026-05-26 2026-05-21 S Sale
2.5
Monges Viviane
Non-Executive Director
9,667 -63.7%
30.29
US$292,853 		9,667 -63.7% 30.29 US$292,853
2026-05-26 2026-05-21 S Sale
Nijdam Anna

Principal Accounting Officer

Officer
1,829 -3.6%
30.60
US$55,971 		1,829 -3.6% 30.60 US$55,971
2026-05-26 2026-05-21 S Sale
Nassif David W.

CFO / CLO

Officer
10,000 -7.7%
30.31
US$303,076 		10,000 -7.7% 30.31 US$303,076
2026-05-21 2026-05-21 PrS Proposed sale
ANNA NIJDAM

Officer

Officer
1,829
30.60
US$55,971 		1,829 30.60 US$55,971
2026-05-21 2026-05-21 PrS Proposed sale
2.5
VIVIANE V. MONGES

Director

Non-Executive Director
9,667
30.29
US$292,853 		9,667 30.29 US$292,853
2026-05-21 2026-05-21 PrS Proposed sale
DAVID NASSIF

Officer

Officer
10,000
30.31
US$303,076 		10,000 30.31 US$303,076
2026-05-22 2026-05-20 PlS Planned sale
2.5
Bjork Elisabeth
Non-Executive Director
10,000 -39.7%
29.32
US$293,166 		10,000 -39.7% 29.32 US$293,166
2026-05-20 2026-05-20 PrS Proposed sale
2.5
ELISABETH BJORK

Director

Non-Executive Director
10,000
29.32
US$293,166 		10,000 29.32 US$293,166
2026-05-20 2026-05-18 PlS Planned sale
Modig Berndt

Chief Executive Officer

Executive Director
2,292 -1.6%
29.22
US$66,977 		2,292 -1.6% 29.22 US$66,977
2026-05-20 2026-05-15 PrS Proposed sale
ROBERT GLASSMAN

Director

Non-Executive Director
10,000
29.82
US$298,245 		10,000 29.82 US$298,245
2026-05-19 2026-05-15 PlS Planned sale
Souverijns Wim

Chief Commercial Officer

Officer
10,000 -18.1%
29.92
US$299,163 		10,000 -18.1% 29.92 US$299,163
2026-05-19 2026-05-15 S Sale
Glassman Robert
Non-Executive Director
4,667 -30.8%
29.82
US$139,155 		4,667 -30.8% 29.82 US$139,155
2026-05-19 2026-05-15 S Sale
Glassman Robert
Non-Executive Director
5,333 -26.0%
29.83
US$159,091 		5,333 -26.0% 29.83 US$159,091
2026-05-19 2026-05-15 S Sale
Abele Stefan Andreas

Chief Technical Ops Officer

Officer
8,748 -19.9%
29.82
US$260,864 		8,748 -19.9% 29.82 US$260,864
2026-05-15 2026-05-15 PrS Proposed sale
WIM SOUVERIJNS

Officer

Officer
10,000
29.92
US$299,163 		10,000 29.92 US$299,163
2026-05-15 2026-05-15 PrS Proposed sale
STEFAN ABELE

Officer

Officer
8,748
29.82
US$260,864 		8,748 29.82 US$260,864
2026-05-15 2026-05-15 PrS Proposed sale
Berndt B.A,E. Modig

Director; Officer

Executive Director
2,292
30.70
US$70,364 		2,292 30.70 US$70,364
2026-05-15 2026-05-15 PrS Proposed sale
ROBERT GLASSMAN

Director

Non-Executive Director
8,804
29.82
US$262,567 		8,804 29.82 US$262,567
2026-05-05 2026-05-01 PlS Planned sale
Lu Peng

Chief Medical Officer

Officer
143 -0.2%
31.00
US$4,433 		143 -0.2% 31.00 US$4,433
2026-05-05 2026-05-01 PlS Planned sale
Lu Peng

Chief Medical Officer

Officer
14,023 -17.5%
30.16
US$422,986 		14,023 -17.5% 30.16 US$422,986
2026-05-01 2026-04-30 PlS Planned sale
Lesage Anne

Chief Early Development

Officer
19,200 -12.5%
30.26
US$580,909 		19,200 -12.5% 30.26 US$580,909
2026-05-01 2026-04-30 PlS Planned sale
Lesage Anne

Chief Early Development

Officer
18,000 -24.2%
30.26
US$544,604 		18,000 -24.2% 30.26 US$544,604
2026-05-01 2026-04-30 PlS Planned sale
Lesage Anne

Chief Early Development

Officer
3,700 -6.2%
30.26
US$111,946 		3,700 -6.2% 30.26 US$111,946
2026-05-01 2026-04-30 PlS Planned sale
Lu Peng

Chief Medical Officer

Officer
15,000 -18.5%
30.24
US$453,627 		15,000 -18.5% 30.24 US$453,627
2026-05-01 2026-04-30 PlS Planned sale
Schikan Johannes Gerardus Christiaan Petrus
Non-Executive Director
670 -0.2%
31.03
US$20,792 		670 -0.2% 31.03 US$20,792
2026-05-01 2026-04-30 PlS Planned sale
Schikan Johannes Gerardus Christiaan Petrus
Non-Executive Director
28,400 -7.4%
30.30
US$860,588 		28,400 -7.4% 30.30 US$860,588
2026-05-01 2026-04-29 PlS Planned sale
Lesage Anne

Chief Early Development

Officer
3,700 -2.4%
30.06
US$111,229 		3,700 -2.4% 30.06 US$111,229
2026-05-01 2026-04-29 PlS Planned sale
Lesage Anne

Chief Early Development

Officer
3,700 -6.2%
30.08
US$111,280 		3,700 -6.2% 30.08 US$111,280
2026-05-01 2026-04-29 PlS Planned sale
Lu Peng

Chief Medical Officer

Officer
3,733 -5.6%
30.06
US$112,232 		3,733 -5.6% 30.06 US$112,232
2026-05-01 2026-04-29 PlS Planned sale
Schikan Johannes Gerardus Christiaan Petrus
Non-Executive Director
3,830 -1.0%
30.07
US$115,165 		3,830 -1.0% 30.07 US$115,165
2026-04-24 2026-04-23 PlS Planned sale
Schikan Johannes Gerardus Christiaan Petrus
Non-Executive Director
100 -0.0%
30.03
US$3,003 		100 -0.0% 30.03 US$3,003
2026-04-24 2026-04-23 PlS Planned sale
Lesage Anne

Chief Early Development

Officer
100 -0.2%
30.03
US$3,003 		100 -0.2% 30.03 US$3,003
2026-04-24 2026-04-23 S Sale
Lesage Anne

Chief Early Development

Officer
100 -0.1%
30.03
US$3,003 		100 -0.1% 30.03 US$3,003
2026-04-24 2026-04-23 PlS Planned sale
Lu Peng

Chief Medical Officer

Officer
100 -0.2%
30.03
US$3,003 		100 -0.2% 30.03 US$3,003
2026-04-24 2026-04-22 PlS Planned sale
Schikan Johannes Gerardus Christiaan Petrus
Non-Executive Director
7,000 -1.8%
30.05
US$210,379 		7,000 -1.8% 30.05 US$210,379
2026-04-24 2026-04-22 S Sale
Lesage Anne

Chief Early Development

Officer
7,000 -4.3%
30.05
US$210,358 		7,000 -4.3% 30.05 US$210,358
2026-04-24 2026-04-22 PlS Planned sale
Lesage Anne

Chief Early Development

Officer
7,000 -11.0%
30.05
US$210,362 		7,000 -11.0% 30.05 US$210,362
2026-04-24 2026-04-22 PlS Planned sale
Lesage Anne

Chief Early Development

Officer
500 -0.9%
30.00
US$15,000 		500 -0.9% 30.00 US$15,000
Explore more

More insider trading research around Pharvaris NV

More insider trades in Netherlands
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe